| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class I protein binding | 6.03e-05 | 32 | 134 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.88e-04 | 17 | 134 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.46e-04 | 130 | 134 | 6 | GO:0005200 | |
| GeneOntologyCellularComponent | leading edge membrane | 8.29e-05 | 210 | 139 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | tubulin complex | 1.31e-04 | 3 | 139 | 2 | GO:0045298 | |
| MousePheno | increased cellular sensitivity to X-ray irradiation | 4.56e-06 | 5 | 109 | 3 | MP:0002879 | |
| MousePheno | abnormal tricuspid valve morphology | 4.58e-05 | 26 | 109 | 4 | MP:0002624 | |
| MousePheno | abnormal precentral gyrus morphology | 5.32e-05 | 10 | 109 | 3 | MP:0000799 | |
| MousePheno | abnormal primary motor cortex morphology | 5.32e-05 | 10 | 109 | 3 | MP:0012448 | |
| Domain | Beta-tubulin_BS | 4.65e-09 | 10 | 136 | 5 | IPR013838 | |
| Domain | Beta_tubulin | 4.65e-09 | 10 | 136 | 5 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 8.48e-09 | 11 | 136 | 5 | PS00228 | |
| Domain | - | 2.70e-07 | 20 | 136 | 5 | 3.30.1330.20 | |
| Domain | - | 3.52e-07 | 21 | 136 | 5 | 1.10.287.600 | |
| Domain | Tubulin_C | 4.53e-07 | 22 | 136 | 5 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 4.53e-07 | 22 | 136 | 5 | IPR018316 | |
| Domain | - | 4.53e-07 | 22 | 136 | 5 | 3.40.50.1440 | |
| Domain | Tubulin_C | 4.53e-07 | 22 | 136 | 5 | SM00865 | |
| Domain | Tub_FtsZ_C | 5.76e-07 | 23 | 136 | 5 | IPR008280 | |
| Domain | Tubulin_C | 5.76e-07 | 23 | 136 | 5 | IPR023123 | |
| Domain | TUBULIN | 5.76e-07 | 23 | 136 | 5 | PS00227 | |
| Domain | Tubulin | 5.76e-07 | 23 | 136 | 5 | IPR000217 | |
| Domain | Tubulin | 5.76e-07 | 23 | 136 | 5 | SM00864 | |
| Domain | Tubulin_CS | 5.76e-07 | 23 | 136 | 5 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 7.23e-07 | 24 | 136 | 5 | IPR003008 | |
| Domain | Tubulin | 7.23e-07 | 24 | 136 | 5 | PF00091 | |
| Domain | DUF4208 | 1.57e-04 | 3 | 136 | 2 | PF13907 | |
| Domain | DUF4208 | 1.57e-04 | 3 | 136 | 2 | IPR025260 | |
| Domain | DUF4208 | 1.57e-04 | 3 | 136 | 2 | SM01176 | |
| Domain | fn3 | 1.86e-04 | 162 | 136 | 7 | PF00041 | |
| Domain | TPR_REGION | 2.08e-04 | 165 | 136 | 7 | PS50293 | |
| Domain | TPR | 2.08e-04 | 165 | 136 | 7 | PS50005 | |
| Domain | FN3 | 4.16e-04 | 185 | 136 | 7 | SM00060 | |
| Domain | MHC_I | 4.56e-04 | 21 | 136 | 3 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 4.56e-04 | 21 | 136 | 3 | IPR001039 | |
| Domain | FN3 | 6.43e-04 | 199 | 136 | 7 | PS50853 | |
| Domain | - | 6.83e-04 | 24 | 136 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 6.83e-04 | 24 | 136 | 3 | IPR011161 | |
| Domain | MHC_I_a_C | 7.75e-04 | 6 | 136 | 2 | IPR010579 | |
| Domain | MHC_I_C | 7.75e-04 | 6 | 136 | 2 | PF06623 | |
| Domain | TPR-contain_dom | 8.10e-04 | 150 | 136 | 6 | IPR013026 | |
| Domain | FN3_dom | 8.58e-04 | 209 | 136 | 7 | IPR003961 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 5.46e-08 | 28 | 107 | 6 | M47898 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.32e-07 | 17 | 107 | 5 | M47768 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.56e-07 | 33 | 107 | 6 | M47901 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.82e-07 | 18 | 107 | 5 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.45e-07 | 19 | 107 | 5 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.45e-07 | 19 | 107 | 5 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 3.25e-07 | 20 | 107 | 5 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 3.25e-07 | 20 | 107 | 5 | M47911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.24e-07 | 21 | 107 | 5 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 5.45e-07 | 22 | 107 | 5 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 6.92e-07 | 23 | 107 | 5 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 6.92e-07 | 23 | 107 | 5 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 8.06e-07 | 43 | 107 | 6 | M47773 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 8.69e-07 | 24 | 107 | 5 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.69e-07 | 24 | 107 | 5 | M47700 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.03e-06 | 102 | 107 | 8 | M27648 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.08e-06 | 25 | 107 | 5 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.08e-06 | 25 | 107 | 5 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.33e-06 | 26 | 107 | 5 | M47672 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.83e-06 | 110 | 107 | 8 | MM15350 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 2.81e-06 | 156 | 107 | 9 | M27097 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 5.16e-06 | 168 | 107 | 9 | MM14785 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 6.21e-06 | 35 | 107 | 5 | M47774 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 6.92e-06 | 17 | 107 | 4 | MM14731 | |
| Pathway | REACTOME_AGGREPHAGY | 7.17e-06 | 36 | 107 | 5 | MM15669 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 1.23e-05 | 187 | 107 | 9 | M961 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 1.34e-05 | 189 | 107 | 9 | MM15356 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.59e-05 | 71 | 107 | 6 | M39690 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.70e-05 | 21 | 107 | 4 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.75e-05 | 43 | 107 | 5 | M47669 | |
| Pathway | REACTOME_AGGREPHAGY | 1.97e-05 | 44 | 107 | 5 | M29830 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.20e-05 | 45 | 107 | 5 | M47670 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 2.27e-05 | 202 | 107 | 9 | MM15650 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 2.37e-05 | 203 | 107 | 9 | M27654 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 2.49e-05 | 23 | 107 | 4 | M19135 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.03e-05 | 48 | 107 | 5 | MM15353 | |
| Pathway | REACTOME_CHL1_INTERACTIONS | 3.45e-05 | 9 | 107 | 3 | M27379 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.70e-05 | 121 | 107 | 7 | M872 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 4.12e-05 | 26 | 107 | 4 | M9648 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 4.49e-05 | 52 | 107 | 5 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 4.49e-05 | 52 | 107 | 5 | MM15211 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 4.81e-05 | 27 | 107 | 4 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 4.81e-05 | 27 | 107 | 4 | MM15674 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.93e-05 | 53 | 107 | 5 | M27651 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 5.40e-05 | 54 | 107 | 5 | M27482 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 5.90e-05 | 55 | 107 | 5 | M39613 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 6.14e-05 | 131 | 107 | 7 | MM15497 | |
| Pathway | KEGG_GAP_JUNCTION | 6.17e-05 | 90 | 107 | 6 | M4013 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 6.17e-05 | 90 | 107 | 6 | MM14979 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 6.44e-05 | 29 | 107 | 4 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 6.44e-05 | 29 | 107 | 4 | M27948 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 6.44e-05 | 56 | 107 | 5 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 7.02e-05 | 57 | 107 | 5 | M27251 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 7.09e-05 | 134 | 107 | 7 | M27751 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | ANK1 COPA CD55 TOR1A TUBB2B CHML TUBB2A NBAS TUBB4A TUBB4B IGF2R SYNJ2 DYNC1LI1 USP6NL TRAPPC9 | 7.95e-05 | 630 | 107 | 15 | M11480 |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 8.35e-05 | 95 | 107 | 6 | M6729 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 9.58e-05 | 32 | 107 | 4 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 9.58e-05 | 32 | 107 | 4 | M27491 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 9.58e-05 | 32 | 107 | 4 | MM14730 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 9.93e-05 | 98 | 107 | 6 | MM15352 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | ANK1 COPA CD55 TOR1A TUBB2B CHML TUBB2A NBAS TUBB4A TUBB4B IGF2R SYNJ2 DYNC1LI1 USP6NL TRAPPC9 | 1.03e-04 | 645 | 107 | 15 | MM15232 |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 1.08e-04 | 33 | 107 | 4 | M27297 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | COL4A1 ANK1 COPA CD55 TOR1A TUBB2B CHML TUBB2A NBAS TUBB4A TUBB4B IGF2R SYNJ2 DYNC1LI1 USP6NL TRAPPC9 | 1.10e-04 | 725 | 107 | 16 | M27507 |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.11e-04 | 100 | 107 | 6 | M27650 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | ANK1 COPA CD55 TUBB2B TUBB2A TUBB4A TUBB4B RNF103 DYNC1LI1 TRAPPC9 | 1.13e-04 | 307 | 107 | 10 | M894 |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 1.45e-04 | 105 | 107 | 6 | MM15206 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.50e-04 | 202 | 107 | 8 | MM15362 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.64e-04 | 68 | 107 | 5 | MM14968 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.71e-04 | 37 | 107 | 4 | MM15102 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.90e-04 | 38 | 107 | 4 | M14981 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.17e-04 | 113 | 107 | 6 | M27471 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.29e-04 | 73 | 107 | 5 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.29e-04 | 73 | 107 | 5 | MM15672 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.31e-04 | 79 | 107 | 5 | M27743 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 3.37e-04 | 44 | 107 | 4 | MM14606 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 3.37e-04 | 44 | 107 | 4 | M27934 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 3.87e-04 | 293 | 107 | 9 | MM15120 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 4.01e-04 | 46 | 107 | 4 | M27828 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.44e-04 | 129 | 107 | 6 | MM14894 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 5.01e-04 | 184 | 107 | 7 | MM15145 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 5.11e-04 | 49 | 107 | 4 | M891 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | NR2C1 ANK1 COPA CD55 RIOX1 TUBB2B CHML TUBB2A USP14 NCOR2 TUBB4A TUBB4B UBA1 PSME4 RNF103 DCAF10 AFP CNTN5 DYNC1LI1 TNKS PRKDC DMP1 TRAPPC9 | 5.93e-04 | 1475 | 107 | 23 | M19806 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 5.96e-04 | 51 | 107 | 4 | M26972 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 6.04e-04 | 90 | 107 | 5 | M29841 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 6.11e-04 | 137 | 107 | 6 | MM15182 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 6.35e-04 | 138 | 107 | 6 | M29805 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 6.65e-04 | 193 | 107 | 7 | MM14890 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.11e-04 | 141 | 107 | 6 | MM15266 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 8.21e-04 | 200 | 107 | 7 | M864 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 8.39e-04 | 6 | 107 | 2 | M47468 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 8.66e-04 | 25 | 107 | 3 | MM1465 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 8.90e-04 | 98 | 107 | 5 | M776 | |
| Pathway | REACTOME_KINESINS | 9.10e-04 | 57 | 107 | 4 | MM15714 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 9.22e-04 | 204 | 107 | 7 | M4217 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 9.82e-04 | 150 | 107 | 6 | M27440 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.17e-03 | 7 | 107 | 2 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.17e-03 | 7 | 107 | 2 | M47530 | |
| Pathway | REACTOME_KINESINS | 1.17e-03 | 61 | 107 | 4 | M977 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.46e-03 | 162 | 107 | 6 | M29804 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.49e-03 | 30 | 107 | 3 | M27216 | |
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 5.45e-11 | 8 | 140 | 5 | 23246003 | |
| Pubmed | 2.52e-10 | 4 | 140 | 4 | 11120798 | ||
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 2.70e-10 | 22 | 140 | 6 | 30446499 | |
| Pubmed | Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells. | 1.25e-09 | 5 | 140 | 4 | 21296049 | |
| Pubmed | 3.75e-09 | 6 | 140 | 4 | 3782288 | ||
| Pubmed | 3.75e-09 | 6 | 140 | 4 | 24275654 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | COPA HLA-B UACA HLA-C AZGP1 POLR2B TUBB CD55 RIOX1 TUBB2B TUBB2A NSRP1 TUBB4A TUBB4B PRKDC PC DDX41 USP6NL MOV10 | 9.84e-09 | 949 | 140 | 19 | 36574265 |
| Pubmed | 1.90e-08 | 21 | 140 | 5 | 30110642 | ||
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 2.45e-08 | 22 | 140 | 5 | 16526095 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 2.45e-08 | 22 | 140 | 5 | 23826228 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 6688039 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | HLA-C TUBB CD55 NASP TUBB2B TUBB4A TUBB4B UBA1 MRPL48 C4BPA PRKDC ABCD1 | 1.57e-07 | 422 | 140 | 12 | 27342126 |
| Pubmed | RBMXL3 COPA UACA TUBB MCM2 TUBB2B CHD1 CHD2 TUBB2A KRT80 TUBB4A TUBB4B UBA1 IGF2R MRPL48 DYNC1LI1 PRKDC DDX41 MOV10 | 2.06e-07 | 1153 | 140 | 19 | 29845934 | |
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 19545277 | ||
| Pubmed | 5.75e-07 | 17 | 140 | 4 | 17360745 | ||
| Pubmed | 5.78e-07 | 40 | 140 | 5 | 30865227 | ||
| Pubmed | Five mouse tubulin isotypes and their regulated expression during development. | 6.35e-07 | 5 | 140 | 3 | 3839797 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 7.91e-07 | 125 | 140 | 7 | 36030824 | |
| Pubmed | 9.30e-07 | 19 | 140 | 4 | 15698476 | ||
| Pubmed | 9.30e-07 | 19 | 140 | 4 | 15691386 | ||
| Pubmed | NR2C1 COPA HLA-B TUBB NAP1L2 NASP TUBB2B TUBB2A RBCK1 SPRYD7 METAP1 TUBB4A TUBB4B FRY TIAM1 MAST1 TNKS PRKDC PC | 1.05e-06 | 1285 | 140 | 19 | 35914814 | |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 27010057 | ||
| Pubmed | 2.45e-06 | 148 | 140 | 7 | 35676246 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 2.47e-06 | 95 | 140 | 6 | 27129302 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | COPA AZGP1 TUBB NASP MCM2 RIOX1 TUBB2B CHD1 NSRP1 METAP1 NCOR2 TUBB4B UBA1 PRKDC PC DDX41 | 2.57e-06 | 989 | 140 | 16 | 36424410 |
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 2.65e-06 | 54 | 140 | 5 | 21525035 | |
| Pubmed | 3.15e-06 | 99 | 140 | 6 | 29676259 | ||
| Pubmed | Serial backcross analysis of genetic resistance to mousepox, using marker loci for Rmp-2 and Rmp-3. | 3.52e-06 | 8 | 140 | 3 | 1433507 | |
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 4.14e-06 | 59 | 140 | 5 | 17330941 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 4.19e-06 | 104 | 140 | 6 | 36055981 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD8 COPA UACA KIZ AZGP1 TUBB TUBGCP6 NBAS TUBB4B UBA1 DCAF10 SYNJ2 DYNC1LI1 PRKDC DDX41 MOV10 RGPD5 | 4.33e-06 | 1155 | 140 | 17 | 20360068 |
| Pubmed | COPA TUBB MCM2 TUBB2B EBF1 NCOR2 TUBB4A TUBB4B DYNC1LI1 PRKDC | 5.05e-06 | 396 | 140 | 10 | 26687479 | |
| Pubmed | COPA UACA HLA-C POLR2B MCM2 CHD1 NSRP1 TUBB4A MRPL48 PRKDC PC DDX41 | 6.23e-06 | 601 | 140 | 12 | 33658012 | |
| Pubmed | 6.35e-06 | 30 | 140 | 4 | 25864199 | ||
| Pubmed | 6.77e-06 | 322 | 140 | 9 | 26514267 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | HLA-B HLA-C CHD1 CHD2 ITGA2 NSRP1 ZNF462 NCOR2 IGF2R NKD1 FHOD1 C6orf120 TNKS PRKDC ABCD1 USP6NL QSOX2 | 7.39e-06 | 1203 | 140 | 17 | 29180619 |
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 37712758 | ||
| Pubmed | Postnatal refinement of auditory hair cell planar polarity deficits occurs in the absence of Vangl2. | 7.50e-06 | 10 | 140 | 3 | 23986237 | |
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 37877672 | ||
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 23869841 | ||
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 38426910 | ||
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 37715782 | ||
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 37219526 | ||
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 37966111 | ||
| Pubmed | 7.98e-06 | 177 | 140 | 7 | 26485645 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | COPA AZGP1 POLR2B TUBB MCM2 TUBB2B CHD1 CHD2 USP14 NCOR2 TUBB4B UBA1 PSME4 FHOD1 DYNC1LI1 PRKDC DDX41 MOV10 | 8.88e-06 | 1353 | 140 | 18 | 29467282 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.15e-05 | 344 | 140 | 9 | 30333137 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | TUBB TUBB2B TUBB2A TUBGCP6 NCOR2 TUBB4A TUBB4B FRY FAT1 PRKDC DDX41 MOV10 | 1.15e-05 | 639 | 140 | 12 | 23443559 |
| Pubmed | 1.20e-05 | 35 | 140 | 4 | 15188402 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD8 COPA HLA-B HLA-C POLR2B TUBB NASP TUBB2B TUBB2A TUBB4A TUBB4B UBA1 PSME4 DYNC1LI1 PRKDC DDX41 RGPD5 | 1.30e-05 | 1257 | 140 | 17 | 37317656 |
| Pubmed | TUBB NASP TUBB2B TUBB2A METAP1 USP14 TUBB4A TUBB4B UBA1 IGF2R FHOD1 DYNC1LI1 PRKDC QSOX2 | 1.33e-05 | 878 | 140 | 14 | 37223481 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.37e-05 | 12 | 140 | 3 | 15331610 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | COPA UACA NASP SLCO4A1 MCM2 TUBGCP6 NCOR2 UBA1 FHOD1 ZBTB40 DYNC1LI1 PRKDC DDX41 | 1.60e-05 | 774 | 140 | 13 | 15302935 |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11972879 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 10885573 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23462218 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 30621030 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 3485286 | ||
| Pubmed | Divergent iron regulatory states contribute to heterogeneity in breast cancer aggressiveness. | 1.61e-05 | 2 | 140 | 2 | 39262774 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19898503 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 26613595 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 14626512 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 17597093 | ||
| Pubmed | Associations between MHC class I and susceptibility to HIV-2 disease progression. | 1.61e-05 | 2 | 140 | 2 | 12352262 | |
| Pubmed | Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. | 1.61e-05 | 2 | 140 | 2 | 18596105 | |
| Pubmed | Angiopoietin 1 attenuates interleukin-6-induced endothelial cell permeability through SHP-1. | 1.61e-05 | 2 | 140 | 2 | 31427082 | |
| Pubmed | Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis. | 1.61e-05 | 2 | 140 | 2 | 18329312 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 29706602 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 20492592 | ||
| Pubmed | HLA-B and C Expression Contributes to COVID-19 Disease Severity within a South African Cohort. | 1.61e-05 | 2 | 140 | 2 | 38674456 | |
| Pubmed | Incompatibility in cell adhesion constitutes a barrier to interspecies chimerism. | 1.61e-05 | 2 | 140 | 2 | 39181131 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 8270253 | ||
| Pubmed | HLA-B and HLA-C alleles and haplotypes in the Dravidian tribal populations of southern India. | 1.61e-05 | 2 | 140 | 2 | 15191523 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 36924504 | ||
| Pubmed | There is more to HLA-C than exons 2 and 3: sequencing exons 1, 4 and 5. | 1.61e-05 | 2 | 140 | 2 | 10488744 | |
| Pubmed | Two new HLA alleles, HLA-B*18:200 and HLA-C*04:435 detected in Russian donors. | 1.61e-05 | 2 | 140 | 2 | 33306271 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 39047119 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9089103 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 14705982 | ||
| Pubmed | HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy. | 1.61e-05 | 2 | 140 | 2 | 32717807 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9234488 | ||
| Pubmed | Association of HLA B*3520, B*1801, and Cw*1507 with HIV-1 infection Maharashtra, India. | 1.61e-05 | 2 | 140 | 2 | 14501803 | |
| Pubmed | HLA polymorphism among Chinese patients with chronic plaque psoriasis: subgroup analysis. | 1.61e-05 | 2 | 140 | 2 | 21985130 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 33815410 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 17920451 | ||
| Pubmed | FHOD1 interaction with nesprin-2G mediates TAN line formation and nuclear movement. | 1.61e-05 | 2 | 140 | 2 | 24880667 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 2000377 | ||
| Pubmed | HLA alleles in pre-menopausal breast cancer patients from western India. | 1.61e-05 | 2 | 140 | 2 | 17085834 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 17480220 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 21037379 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 30262880 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 16439971 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 17627938 | ||
| Pubmed | Sequence of four new HLA-Cw alleles: a possible role of interallelic recombination. | 1.61e-05 | 2 | 140 | 2 | 9459506 | |
| Pubmed | CHD1 and CHD2 are positive regulators of HIV-1 gene expression. | 1.61e-05 | 2 | 140 | 2 | 25297984 | |
| Pubmed | A reliable and efficient high resolution typing method for HLA-C using sequence-based typing. | 1.61e-05 | 2 | 140 | 2 | 9894855 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 37057874 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23935489 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22586163 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 20604894 | ||
| Interaction | TPSB2 interactions | 1.40e-09 | 18 | 135 | 6 | int:TPSB2 | |
| Interaction | BAGE2 interactions | 2.19e-08 | 70 | 135 | 8 | int:BAGE2 | |
| Interaction | CAPS interactions | 5.97e-07 | 25 | 135 | 5 | int:CAPS | |
| Interaction | KLK5 interactions | 7.08e-07 | 109 | 135 | 8 | int:KLK5 | |
| Interaction | ZC2HC1B interactions | 1.09e-06 | 28 | 135 | 5 | int:ZC2HC1B | |
| Interaction | IL12RB1 interactions | 1.94e-06 | 87 | 135 | 7 | int:IL12RB1 | |
| Interaction | AIRE interactions | 4.03e-06 | 97 | 135 | 7 | int:AIRE | |
| Interaction | GABRA1 interactions | 8.59e-06 | 152 | 135 | 8 | int:GABRA1 | |
| Interaction | RIPK4 interactions | COPA HLA-B POLR2B TUBB NASP TUBB2B TUBB2A TUBGCP6 TUBB4A TUBB4B UBA1 MRPL48 PRKDC | 9.71e-06 | 446 | 135 | 13 | int:RIPK4 |
| Interaction | TCP11L1 interactions | 1.11e-05 | 75 | 135 | 6 | int:TCP11L1 | |
| Interaction | RGPD4 interactions | 1.28e-05 | 22 | 135 | 4 | int:RGPD4 | |
| Interaction | TNIP1 interactions | ABHD17A COPA HLA-B UACA HLA-C AZGP1 POLR2B TUBB CD55 LAMA4 RIOX1 TUBB2B TUBB2A NSRP1 RBCK1 TUBB4A TUBB4B PRKDC PC DDX41 USP6NL MOV10 | 1.90e-05 | 1217 | 135 | 22 | int:TNIP1 |
| Interaction | PPEF1 interactions | 2.53e-05 | 52 | 135 | 5 | int:PPEF1 | |
| Interaction | LILRB1 interactions | 3.41e-05 | 10 | 135 | 3 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 3.41e-05 | 10 | 135 | 3 | int:LILRB2 | |
| GeneFamily | Tubulins | 2.54e-07 | 26 | 98 | 5 | 778 | |
| GeneFamily | Fibronectin type III domain containing | 2.35e-04 | 160 | 98 | 6 | 555 | |
| GeneFamily | Cation channels sperm associated | 6.00e-04 | 7 | 98 | 2 | 186 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.27e-03 | 10 | 98 | 2 | 100 | |
| GeneFamily | C1-set domain containing | 1.52e-03 | 42 | 98 | 3 | 591 | |
| GeneFamily | Ankyrin repeat domain containing | 2.04e-03 | 242 | 98 | 6 | 403 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.54e-03 | 115 | 98 | 4 | 769 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.66e-03 | 57 | 98 | 3 | 1179 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL4A1 COPA UACA TUBB FKBP9 LAMA4 EXT1 EBF1 ITGA2 ADA FAT1 NKD1 SYNJ2 FHOD1 PRKG1 | 3.54e-06 | 681 | 139 | 15 | M39175 |
| Coexpression | PURWIN_A375_SOX10_TARGETS | 1.10e-05 | 55 | 139 | 5 | M48227 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN | 1.20e-05 | 200 | 139 | 8 | M8398 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | NR2C1 POLR2B NASP MCM2 LCT ADA RBCK1 METAP1 SEPHS1 FAT1 PRKDC | 1.78e-05 | 426 | 139 | 11 | M9516 |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 2.41e-05 | 160 | 139 | 7 | M6876 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 2.43e-05 | 32 | 139 | 4 | MM657 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 2.61e-05 | 162 | 139 | 7 | M45037 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 2.75e-05 | 33 | 139 | 4 | M7409 | |
| Coexpression | IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP | 6.34e-05 | 15 | 139 | 3 | M2152 | |
| Coexpression | ABRAMSON_INTERACT_WITH_AIRE | 8.72e-05 | 44 | 139 | 4 | M2536 | |
| Coexpression | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN | 8.72e-05 | 44 | 139 | 4 | MM805 | |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 9.59e-05 | 199 | 139 | 7 | M9178 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 9.63e-05 | 86 | 139 | 5 | M39247 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C5 | 1.04e-04 | 46 | 139 | 4 | M1470 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-08 | 197 | 140 | 9 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-08 | 200 | 140 | 9 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.07e-07 | 180 | 140 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.21e-07 | 183 | 140 | 8 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.49e-07 | 188 | 140 | 8 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 2.05e-07 | 196 | 140 | 8 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-07 | 199 | 140 | 8 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.31e-07 | 199 | 140 | 8 | 9021f4be004efd51bb3658e5bbff53589356b3df | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-07 | 199 | 140 | 8 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.40e-07 | 200 | 140 | 8 | d36236c7703b759309c8347f44900fc4bed377f0 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-07 | 139 | 140 | 7 | 2fdc8f36510aff24abbc79ef2a842db75a85f946 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-07 | 139 | 140 | 7 | 5970a654c64e3b54f9d18c102f5b125eec892fc5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-06 | 172 | 140 | 7 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-06 | 173 | 140 | 7 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.61e-06 | 179 | 140 | 7 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.80e-06 | 182 | 140 | 7 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 2.24e-06 | 188 | 140 | 7 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-06 | 189 | 140 | 7 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | LAM-Endothelial-VasEndo-1|LAM / Condition, Lineage and Cell class | 2.32e-06 | 189 | 140 | 7 | 454e64b1ee93edebbc1576fbf7c3a6db332fa927 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-06 | 189 | 140 | 7 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-06 | 190 | 140 | 7 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.40e-06 | 190 | 140 | 7 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.40e-06 | 190 | 140 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-06 | 68 | 140 | 5 | f1cbc6d72489272c1eb6200f64b8b6444719acda | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 191 | 140 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-06 | 191 | 140 | 7 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.48e-06 | 191 | 140 | 7 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 2.57e-06 | 192 | 140 | 7 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 2.57e-06 | 192 | 140 | 7 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.57e-06 | 192 | 140 | 7 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.66e-06 | 193 | 140 | 7 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.66e-06 | 193 | 140 | 7 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.66e-06 | 193 | 140 | 7 | 8187f976fd2d11fad3286690f1a046e894772220 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.75e-06 | 194 | 140 | 7 | b8aa48d7774e4da3351ee2177eb694fcfec7cbc3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 195 | 140 | 7 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 195 | 140 | 7 | a52ee3ad6cd317f10b9308450517861ef2e363bb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-06 | 195 | 140 | 7 | b3660779f274ca97dd844cf83f62d85ba88cb182 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.85e-06 | 195 | 140 | 7 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 196 | 140 | 7 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 196 | 140 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 196 | 140 | 7 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 196 | 140 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | (7)_Epithelial-B_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.95e-06 | 196 | 140 | 7 | 345d4cc062b43bca9d506fbf23363469a9ba496f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 196 | 140 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 196 | 140 | 7 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.05e-06 | 197 | 140 | 7 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-06 | 197 | 140 | 7 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 3.05e-06 | 197 | 140 | 7 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | medial-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.26e-06 | 199 | 140 | 7 | c5048b31649a0b7eddcd481b0458ed96508f5561 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.26e-06 | 199 | 140 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.26e-06 | 199 | 140 | 7 | b44712baede833ddbac3699162b7eeb6ede2af27 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.26e-06 | 199 | 140 | 7 | a5c2c676fc0dd4f0422fbcae34ad6d734edd5349 | |
| ToppCell | distal-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.26e-06 | 199 | 140 | 7 | bf70c8bfe932bccac5014e55f82019c5148627e7 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.26e-06 | 199 | 140 | 7 | 84e30c39c2f050aa64af167999824c1cba32ba05 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.26e-06 | 199 | 140 | 7 | c8bc05dece8b8a87d4a7a3e8112b924e15217de1 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.26e-06 | 199 | 140 | 7 | 78b245d40c1e169ff2d26907b63d732e34529c5f | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.26e-06 | 199 | 140 | 7 | f1039d1ab498fc58f0feba545df05833c235db74 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.26e-06 | 199 | 140 | 7 | 8e1e95c3a4b856415af208be6ad977e575bac189 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.37e-06 | 200 | 140 | 7 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-06 | 200 | 140 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | distal-Endothelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-06 | 200 | 140 | 7 | b17c9607d4986f8f1facc6b564d4c15c48e58915 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-06 | 200 | 140 | 7 | b91f8eb67752a77e1e08e462e50f1b5923695e1b | |
| ToppCell | distal-2-Endothelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-06 | 200 | 140 | 7 | bc1781cff7a4602057a59ef65cf16c3a9459c628 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-05 | 165 | 140 | 6 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 170 | 140 | 6 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 170 | 140 | 6 | a6fa0cab1fa829ec601fe48306b4c43c83425b04 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 170 | 140 | 6 | b40255eee45eb18b5a297336d7f3845fd8f8aa3b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 170 | 140 | 6 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 173 | 140 | 6 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-05 | 173 | 140 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.88e-05 | 174 | 140 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-05 | 174 | 140 | 6 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-05 | 175 | 140 | 6 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-05 | 176 | 140 | 6 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-05 | 176 | 140 | 6 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.07e-05 | 177 | 140 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | CD8+_Memory_T_cell-FLU-5|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.20e-05 | 179 | 140 | 6 | 7f18dffa85285599662edbcd3f32ab42672bffb8 | |
| ToppCell | Control-Stromal-SMC|Control / Disease state, Lineage and Cell class | 2.20e-05 | 179 | 140 | 6 | 1378051bc62009eec2dbecf3d5d89baedbeb84eb | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.27e-05 | 180 | 140 | 6 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.27e-05 | 180 | 140 | 6 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.34e-05 | 181 | 140 | 6 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.34e-05 | 181 | 140 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Pericytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.42e-05 | 182 | 140 | 6 | 46c213597445b1f4f09dc367f27702d24b201daf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 182 | 140 | 6 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 182 | 140 | 6 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-05 | 183 | 140 | 6 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-05 | 183 | 140 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | Pericytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.57e-05 | 184 | 140 | 6 | cd10d351d91a81dd6dc806cb4e0c8d7861c98e0b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 140 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 140 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 184 | 140 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Stromal-SMC|World / Disease state, Lineage and Cell class | 2.57e-05 | 184 | 140 | 6 | 88b1a4c9a96a99fc3a39f7a2c3d0838739606f3e | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.65e-05 | 185 | 140 | 6 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-05 | 186 | 140 | 6 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-05 | 186 | 140 | 6 | 4a5264e32ba004ed58dc4102d84e4bc4dbbe1440 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-05 | 186 | 140 | 6 | 528ee88f6e27863c7bcdffd4416cbbd83fc65e9d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 186 | 140 | 6 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-05 | 186 | 140 | 6 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-05 | 186 | 140 | 6 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.81e-05 | 187 | 140 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| Drug | NSC72302 | 1.32e-08 | 28 | 135 | 6 | CID000118078 | |
| Drug | discodermolide | 5.48e-08 | 35 | 135 | 6 | CID000643668 | |
| Drug | baccatin III | 7.77e-08 | 37 | 135 | 6 | CID000065366 | |
| Drug | 2,3,4-tabp | 2.10e-07 | 23 | 135 | 5 | CID000125548 | |
| Drug | NSC355636 | 2.10e-07 | 23 | 135 | 5 | CID000100176 | |
| Drug | IKP104 | 2.10e-07 | 23 | 135 | 5 | CID000130739 | |
| Drug | 2,3,4-TCB | 2.10e-07 | 23 | 135 | 5 | CID000129239 | |
| Drug | N-acetylcolchinol | 2.10e-07 | 23 | 135 | 5 | CID000097865 | |
| Drug | parbendazole | 2.64e-07 | 24 | 135 | 5 | CID000026596 | |
| Drug | tropolone methyl ether | 2.64e-07 | 24 | 135 | 5 | CID000016546 | |
| Drug | AC1L4TG7 | 2.64e-07 | 24 | 135 | 5 | CID000163705 | |
| Drug | NSC-36768 | 2.64e-07 | 24 | 135 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 2.64e-07 | 24 | 135 | 5 | CID000014995 | |
| Drug | colchicide | 2.64e-07 | 24 | 135 | 5 | CID000120712 | |
| Drug | AC1Q6P06 | 3.29e-07 | 25 | 135 | 5 | CID000160263 | |
| Drug | allocolchicine | 3.29e-07 | 25 | 135 | 5 | CID000196989 | |
| Drug | 55623-37-5 | 3.29e-07 | 25 | 135 | 5 | CID006438440 | |
| Drug | MDL 27048 | 3.29e-07 | 25 | 135 | 5 | CID006439188 | |
| Drug | NBD-colcemid | 3.29e-07 | 25 | 135 | 5 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 3.29e-07 | 25 | 135 | 5 | CID000043264 | |
| Drug | NSC527981 | 4.05e-07 | 26 | 135 | 5 | CID000352796 | |
| Drug | NSC332029 | 4.05e-07 | 26 | 135 | 5 | CID000100073 | |
| Drug | pironetin | 4.05e-07 | 26 | 135 | 5 | CID006438891 | |
| Drug | AC1L1J4H | 4.95e-07 | 27 | 135 | 5 | CID000004862 | |
| Drug | dinitroanilines | 4.95e-07 | 27 | 135 | 5 | CID000136400 | |
| Drug | NSC292222 | 4.95e-07 | 27 | 135 | 5 | CID000099957 | |
| Drug | NSC D-669356 | 4.95e-07 | 27 | 135 | 5 | CID000178028 | |
| Drug | GaCl3 | 4.98e-07 | 50 | 135 | 6 | CID000026010 | |
| Drug | NSC 370147 | 5.99e-07 | 28 | 135 | 5 | CID000182762 | |
| Drug | oxibendazole | 7.21e-07 | 29 | 135 | 5 | CID000004622 | |
| Drug | AC1NBBHE | 8.61e-07 | 30 | 135 | 5 | CID004490620 | |
| Drug | eleutherobin | 8.61e-07 | 30 | 135 | 5 | CID006918335 | |
| Drug | azatoxin | 8.61e-07 | 30 | 135 | 5 | CID000125383 | |
| Drug | NSC617668 | 8.61e-07 | 30 | 135 | 5 | CID000357989 | |
| Drug | citostal | 8.61e-07 | 30 | 135 | 5 | CID000018991 | |
| Drug | thiocolchicine | 8.61e-07 | 30 | 135 | 5 | CID000017648 | |
| Drug | AC1L8WWP | 9.89e-07 | 56 | 135 | 6 | CID000388944 | |
| Drug | NSC609395 | 1.02e-06 | 31 | 135 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 1.02e-06 | 31 | 135 | 5 | CID000100524 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 1.02e-06 | 31 | 135 | 5 | CID000032851 | |
| Drug | tropone | 1.02e-06 | 31 | 135 | 5 | CID000010881 | |
| Drug | AC1L3V8I | 1.02e-06 | 31 | 135 | 5 | CID000122777 | |
| Drug | NSC332598 | 1.02e-06 | 31 | 135 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 1.02e-06 | 31 | 135 | 5 | CID000023678 | |
| Drug | AC1L1G95 | 1.20e-06 | 32 | 135 | 5 | CID000003583 | |
| Drug | NSC153858 | 1.20e-06 | 32 | 135 | 5 | CID000547450 | |
| Drug | 2-demethylcolchicine | 1.20e-06 | 32 | 135 | 5 | CID000023757 | |
| Drug | mebendazole | 1.41e-06 | 33 | 135 | 5 | CID000004030 | |
| Drug | CA4P | 1.41e-06 | 33 | 135 | 5 | CID000370232 | |
| Drug | taltobulin | 1.41e-06 | 33 | 135 | 5 | CID006918637 | |
| Drug | NSC376450 | 1.65e-06 | 34 | 135 | 5 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 1.65e-06 | 34 | 135 | 5 | CID000161091 | |
| Drug | AC1O5Y0F | 2.55e-06 | 37 | 135 | 5 | CID006442852 | |
| Drug | DTAF | 2.55e-06 | 37 | 135 | 5 | CID000123934 | |
| Drug | albendazole | 2.55e-06 | 37 | 135 | 5 | CID000002082 | |
| Drug | gnoscopine | 2.92e-06 | 38 | 135 | 5 | CID000004544 | |
| Drug | laulimalide | 2.92e-06 | 38 | 135 | 5 | CID006918457 | |
| Drug | colchiceine | 2.92e-06 | 38 | 135 | 5 | CID000010156 | |
| Drug | erianin | 3.33e-06 | 39 | 135 | 5 | CID000356759 | |
| Drug | Dolastatin 10 | 3.33e-06 | 39 | 135 | 5 | CID000100208 | |
| Drug | AC1L8GZ1 | 3.79e-06 | 40 | 135 | 5 | CID000381235 | |
| Drug | HgCl2 | 3.96e-06 | 263 | 135 | 10 | CID000024085 | |
| Drug | lumicolchicine | 4.29e-06 | 41 | 135 | 5 | CID000072624 | |
| Drug | AC1L1KMJ | COL4A1 ANK1 TUBB LAMA4 TUBB2B ITGA2 TUBB2A TUBB4A TUBB4B PTPN6 TIAM1 APEX2 C4BPA | 5.34e-06 | 476 | 135 | 13 | CID000030956 |
| Drug | AC1L9CY0 | 5.46e-06 | 43 | 135 | 5 | CID000396644 | |
| Drug | Stylophorin | 5.46e-06 | 43 | 135 | 5 | CID000010147 | |
| Drug | thiabendazole | 6.05e-06 | 76 | 135 | 6 | CID000005430 | |
| Drug | bromocolchicine | 6.54e-06 | 21 | 135 | 4 | CID000161518 | |
| Drug | colchifoline | 6.54e-06 | 21 | 135 | 4 | CID000100132 | |
| Drug | Ustiloxin A | 6.54e-06 | 21 | 135 | 4 | CID000164454 | |
| Drug | SRI-3072 | 6.54e-06 | 21 | 135 | 4 | CID000493469 | |
| Drug | methyl ether | 6.87e-06 | 45 | 135 | 5 | CID000008254 | |
| Drug | 3,4,5-trimethoxyacetophenone | 7.96e-06 | 22 | 135 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 7.96e-06 | 22 | 135 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 7.96e-06 | 22 | 135 | 4 | CID000098538 | |
| Drug | SureCN13401588 | 7.96e-06 | 22 | 135 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 7.96e-06 | 22 | 135 | 4 | CID000023759 | |
| Drug | NSC-339672 | 7.96e-06 | 22 | 135 | 4 | CID000433930 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 9.59e-06 | 23 | 135 | 4 | CID000006858 | |
| Drug | AC1L2P05 | 9.59e-06 | 23 | 135 | 4 | CID000125688 | |
| Drug | NSC-373301 | 9.59e-06 | 23 | 135 | 4 | CID000341375 | |
| Drug | fluorescein-colchicine | 9.59e-06 | 23 | 135 | 4 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 9.59e-06 | 23 | 135 | 4 | CID000084076 | |
| Drug | NSC654663 | 1.05e-05 | 49 | 135 | 5 | CID000375252 | |
| Drug | AC1L491G | 1.15e-05 | 24 | 135 | 4 | CID000152771 | |
| Drug | 7-epi-cephalomannine | 1.15e-05 | 24 | 135 | 4 | CID000330401 | |
| Drug | NABV | 1.15e-05 | 24 | 135 | 4 | CID000175959 | |
| Drug | moscatilin | 1.15e-05 | 24 | 135 | 4 | CID000176096 | |
| Drug | Z)-combretastatin A-4 | 1.16e-05 | 50 | 135 | 5 | CID000072686 | |
| Drug | 2-nitroimidazole | 1.21e-05 | 129 | 135 | 7 | CID000010701 | |
| Drug | combretastatin | 1.28e-05 | 51 | 135 | 5 | CID000100154 | |
| Drug | mpMap | 1.36e-05 | 25 | 135 | 4 | CID000100806 | |
| Drug | 1069C85 | 1.36e-05 | 25 | 135 | 4 | CID006918099 | |
| Drug | 2,4,3',5'-tetramethoxystilbene | 1.36e-05 | 25 | 135 | 4 | ctd:C440850 | |
| Drug | CA1P | 1.36e-05 | 25 | 135 | 4 | CID006918545 | |
| Drug | peloruside A | 1.36e-05 | 25 | 135 | 4 | CID006918506 | |
| Drug | NSC142227 | 1.36e-05 | 25 | 135 | 4 | CID000073427 | |
| Drug | magnesium sulfate | 1.41e-05 | 52 | 135 | 5 | CID000024083 | |
| Drug | vinflunine | 1.41e-05 | 52 | 135 | 5 | CID000157688 | |
| Drug | tropolone | 1.55e-05 | 53 | 135 | 5 | CID000010789 | |
| Disease | ptosis (implicated_via_orthology) | 3.52e-10 | 10 | 128 | 5 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 3.52e-10 | 10 | 128 | 5 | DOID:0112227 (implicated_via_orthology) | |
| Disease | facial paralysis (implicated_via_orthology) | 3.52e-10 | 10 | 128 | 5 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 3.52e-10 | 10 | 128 | 5 | DOID:0090132 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 1.10e-09 | 12 | 128 | 5 | DOID:0050997 (implicated_via_orthology) | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 4.39e-06 | 8 | 128 | 3 | DOID:14452 (implicated_via_orthology) | |
| Disease | reticulocyte count | ANGPT1 ANK1 HLA-C TUBB FKBP9 LAMA4 IP6K1 EBF1 FAT1 DCAF10 CNTN5 SYNE2 ZBTB40 MAST1 C4BPA SPOCD1 | 1.24e-05 | 1045 | 128 | 16 | EFO_0007986 |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 3.38e-05 | 206 | 128 | 7 | EFO_0004612, EFO_0020947 | |
| Disease | reticulocyte measurement | ANGPT1 ANK1 HLA-C TUBB FKBP9 IP6K1 EBF1 FAT1 CNTN5 SYNE2 ZBTB40 MAST1 MYH15 C4BPA SPOCD1 | 5.39e-05 | 1053 | 128 | 15 | EFO_0010700 |
| Disease | COVID-19 (is_implicated_in) | 1.00e-04 | 21 | 128 | 3 | DOID:0080600 (is_implicated_in) | |
| Disease | allergic asthma (is_implicated_in) | 1.85e-04 | 5 | 128 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | cleft lip | 2.49e-04 | 284 | 128 | 7 | EFO_0003959 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 3.87e-04 | 7 | 128 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.49e-04 | 224 | 128 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | thyroxine measurement | 4.76e-04 | 83 | 128 | 4 | EFO_0005130 | |
| Disease | serum IgG glycosylation measurement | 4.77e-04 | 523 | 128 | 9 | EFO_0005193 | |
| Disease | cervical cancer (is_marker_for) | 5.13e-04 | 36 | 128 | 3 | DOID:4362 (is_marker_for) | |
| Disease | Liver Cirrhosis, Experimental | 5.69e-04 | 774 | 128 | 11 | C0023893 | |
| Disease | autism spectrum disorder | 6.08e-04 | 156 | 128 | 5 | EFO_0003756 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 7.53e-04 | 41 | 128 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | epilepsy | 7.53e-04 | 41 | 128 | 3 | EFO_0000474 | |
| Disease | amino acid measurement | 7.67e-04 | 678 | 128 | 10 | EFO_0005134 | |
| Disease | Nephroblastoma | 8.21e-04 | 10 | 128 | 2 | Orphanet_654 | |
| Disease | Alzheimer disease, APOE carrier status | 8.91e-04 | 98 | 128 | 4 | EFO_0007659, MONDO_0004975 | |
| Disease | amyloid-beta measurement | 9.37e-04 | 355 | 128 | 7 | EFO_0005194 | |
| Disease | adipose tissue measurement | 9.90e-04 | 45 | 128 | 3 | EFO_0004764 | |
| Disease | beta-2 microglobulin measurement | 1.00e-03 | 11 | 128 | 2 | EFO_0005197 | |
| Disease | endometrial adenocarcinoma (is_marker_for) | 1.00e-03 | 11 | 128 | 2 | DOID:2870 (is_marker_for) | |
| Disease | Retinitis Pigmentosa | 1.11e-03 | 104 | 128 | 4 | C0035334 | |
| Disease | cervical carcinoma | 1.21e-03 | 182 | 128 | 5 | EFO_0001061 | |
| Disease | psoriasis | 1.26e-03 | 273 | 128 | 6 | EFO_0000676 | |
| Disease | susceptibility to measles measurement | 1.27e-03 | 49 | 128 | 3 | EFO_0008414 | |
| Disease | diabetic retinopathy (is_implicated_in) | 1.35e-03 | 50 | 128 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | bone fracture | 1.46e-03 | 112 | 128 | 4 | EFO_0003931 | |
| Disease | Behcet's syndrome | 1.59e-03 | 53 | 128 | 3 | EFO_0003780 | |
| Disease | urinary nitrogen measurement | 1.64e-03 | 14 | 128 | 2 | EFO_0005190 | |
| Disease | platelet component distribution width | COL4A1 ANGPT1 HLA-B TUBB ITGA2 NCOR2 SYNJ2 CNTN5 C4BPA RNF145 | 1.71e-03 | 755 | 128 | 10 | EFO_0007984 |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 1.89e-03 | 15 | 128 | 2 | EFO_0801746 | |
| Disease | platelet measurement | 2.58e-03 | 315 | 128 | 6 | EFO_0005036 | |
| Disease | mean reticulocyte volume | ANGPT1 ANK1 HLA-B CHD1 IDUA TUBB2A CNTN5 ZBTB40 MAST1 TRAPPC9 | 2.58e-03 | 799 | 128 | 10 | EFO_0010701 |
| Disease | vital capacity | POLR2B EBF1 OMD LCT KCNH3 USP14 NCOR2 ZBTB40 PRKG1 PC ANKFN1 QSOX2 MOV10 | 2.82e-03 | 1236 | 128 | 13 | EFO_0004312 |
| Disease | susceptibility to cold sores measurement | 2.86e-03 | 65 | 128 | 3 | EFO_0008402 | |
| Disease | mitochondrial DNA measurement | 3.15e-03 | 328 | 128 | 6 | EFO_0006312 | |
| Disease | phospholipid measurement | 3.29e-03 | 140 | 128 | 4 | EFO_0004639 | |
| Disease | Severe Combined Immunodeficiency | 3.37e-03 | 20 | 128 | 2 | C0085110 | |
| Disease | gastric ulcer (biomarker_via_orthology) | 3.71e-03 | 21 | 128 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | Leber Congenital Amaurosis | 4.07e-03 | 22 | 128 | 2 | C0339527 | |
| Disease | Retinitis pigmentosa | 4.13e-03 | 74 | 128 | 3 | cv:C0035334 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 4.20e-03 | 150 | 128 | 4 | EFO_0004611, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGISHDFQGRYRYLN | 101 | A0A1B0GUX0 | |
| SHAQYQLLFEGLRDG | 776 | Q6UXC1 | |
| IRNGRHSGEENFYAY | 181 | P04003 | |
| LGHGYHTLEDQALYN | 236 | P00813 | |
| RPQYLGENLSHYSSG | 151 | Q8NEC5 | |
| YHYDRQAEIIGSLGG | 186 | Q86XM0 | |
| AGNYSYLRLNHEGKI | 51 | Q7Z4R8 | |
| HGYLGLNSQQVEYLV | 351 | Q8NHS2 | |
| YISNGCLLNYLRSHG | 491 | P51813 | |
| RSRYGESYLDQILNG | 1021 | P16157 | |
| HQLHTYYQLGRGSSD | 1406 | Q9HAR2 | |
| LYHDALQNYTGGNLT | 121 | Q96PS8 | |
| GAGHNDIELYSQYLE | 281 | Q96GS6 | |
| EGNRAYSQYDRFHIG | 381 | Q15389 | |
| GARHLNYGSRLDYVL | 266 | Q9UBZ4 | |
| HYDYQTLRIGGLVFA | 31 | Q9H0Q3 | |
| SYIGGHEGLELRDYQ | 471 | O14646 | |
| YSLLYVQGNERAHGQ | 1471 | P02462 | |
| EGNTLYHFTVRAYNG | 941 | O94779 | |
| RNHYLDLAGIENYTS | 256 | Q969G9 | |
| GQRVLHIDSRSYYGG | 31 | P26374 | |
| EYLNVHYIGESASRL | 386 | P13056 | |
| SGFYRHLLNQAVGEE | 181 | Q9H0G5 | |
| GNDDFLLGHNLRTYI | 386 | Q9ULW6 | |
| HYGRDNLLDTYSADQ | 561 | Q6ZRP7 | |
| NSFYGQLEYIGRSVH | 591 | Q99666 | |
| NSFYGQLEYIGRSVH | 591 | O14715 | |
| DNLDYRLGAIHSLVY | 476 | O60890 | |
| GEYLIHQGDALQALY | 606 | Q9ULD8 | |
| EIELTGIYHNNYDGS | 411 | P49736 | |
| YGGHEVELALLQRSY | 296 | P33897 | |
| SNLNGVYYRLGEHNK | 301 | O43827 | |
| VDRDSGRNGEVHYYL | 2106 | Q14517 | |
| YDSGDRQGLLSAYHD | 356 | Q9H4D5 | |
| QELELRSLGYHGSSY | 2031 | Q9Y618 | |
| IVNVDITLYRNGYHG | 216 | P53582 | |
| ITLYRNGYHGDLNET | 221 | P53582 | |
| YNRDSNLDVIAHGYQ | 231 | Q8IV33 | |
| LEGRRYHIYENGTLQ | 466 | O00533 | |
| IDGHFYNRIYEAGSE | 46 | Q9Y692 | |
| GFHLSRYGYQNDAEI | 1201 | Q2M2H8 | |
| SHGVRQNGDSAYLYL | 116 | Q9BYM8 | |
| HYENGEYIIRQGARG | 241 | Q13976 | |
| ERGRDTHLYTEYTLQ | 146 | Q99665 | |
| FDLGHLYEEYQGRLQ | 126 | Q6KB66 | |
| IDNGIIQGERDHYGY | 231 | P08174 | |
| IQGERDHYGYRQSVT | 236 | P08174 | |
| GRGLEYLYLNVHDED | 96 | Q9Y6G9 | |
| YTRQILQGLGYLHDN | 751 | O95382 | |
| RGYYNQSEDGSHTLQ | 106 | P10321 | |
| YSCRHGYELQGREQL | 766 | P07202 | |
| LTHYIEEANVGRGYI | 461 | Q5QP82 | |
| SINSHGVDYYNRLIN | 991 | P09848 | |
| THLTHYGIYLGDNRV | 56 | O95237 | |
| QAYLAGLAGQYHLER | 1416 | Q96RT7 | |
| YGNHKYGLNRDTVEG | 486 | Q96M69 | |
| LEHGEYEGNLYGTRI | 441 | Q14168 | |
| SRELARQTHGILEYY | 266 | Q9UJV9 | |
| LGSDDHQYIYRLAGG | 76 | Q13316 | |
| YYERLGQLQHGLRDS | 16 | Q2M2Z5 | |
| YYTQELGVRERSGHS | 441 | Q68DD2 | |
| RGYYNQSEAGSHTLQ | 106 | P01889 | |
| GESHQYNADYVRGRL | 71 | P0DTE2 | |
| QILQDRNHSSYLGYS | 426 | P17301 | |
| AHTYGLDTDLVYQRQ | 546 | A2RRP1 | |
| RLLAETHYQLGLAYG | 581 | P49321 | |
| SNGAYGAVYLVRHRD | 381 | Q9Y2H9 | |
| QSGDFLRYHYNGTLL | 276 | O95302 | |
| YRSDFYSLQEQHLGL | 441 | Q9H094 | |
| TFGRLTLHNTDLGYY | 4901 | Q4G0P3 | |
| YLTGIGSDTRNALYH | 271 | Q16394 | |
| GDHYTNGLYSLIQRS | 211 | Q9UG22 | |
| DSRLLLGIYEHGYGN | 1266 | O14647 | |
| GHYQNALYLGDVSER | 731 | P53621 | |
| IDTQDIEASHYRGYG | 1381 | P01031 | |
| NGIHYRLQLLYSNGI | 106 | Q9UH73 | |
| RDNAIYGEHGDLYIT | 226 | P60827 | |
| GLSYNFTHLDGYLDL | 106 | P35475 | |
| SAHYGNNYRDVLQDL | 796 | Q6ZN28 | |
| IEGFRNALYQYLHNG | 286 | Q92551 | |
| EGGIHTQRRYGSIYT | 151 | Q8NEP7 | |
| YFRHQTLGQTGTYAL | 2951 | Q5TBA9 | |
| AADHNYQSYILRALG | 171 | Q9Y613 | |
| IYRYGNHTGEFISLQ | 296 | O00237 | |
| ETGNLAASYHLARQY | 1006 | Q96RY7 | |
| LRFEGQITVYHYDGG | 206 | O95396 | |
| YVGQNLSIHSGQYRS | 116 | Q9H3Y0 | |
| LAASQGHSLAQYRYA | 306 | Q14154 | |
| LHRNEYGIASILDSY | 21 | P02771 | |
| IEHAYQYGGTANSRQ | 1466 | Q16363 | |
| RTNYRAGYQGAHDLL | 61 | Q96AX9 | |
| AGYQGAHDLLLYDNA | 66 | Q96AX9 | |
| HIHTIYYGEQRSTNG | 356 | Q99983 | |
| GRYHNQTLRYSDGDL | 396 | P11717 | |
| ILIHNSSELSYRAYG | 2281 | O75445 | |
| LYREDGSGQQVHYET | 4556 | Q8WXH0 | |
| ALQYYGRAELQASDH | 841 | O15056 | |
| HGLGYSLLERLLTYN | 696 | Q9HCE1 | |
| YGNLSRDEGQLYHLL | 21 | Q9H3E2 | |
| AGERNYHIFYQILSG | 291 | Q9Y2K3 | |
| GQCQDLREAYRYTHG | 141 | A1L4K1 | |
| YDRIIEGHYNGEQLG | 356 | Q9HCL2 | |
| LDYINGGELFYHLQR | 176 | O00141 | |
| RHGGLSLVQTTDYIY | 76 | P49903 | |
| ISNLLSDYGYHLRGN | 1011 | P30876 | |
| NLGTDYEYGVLNIHL | 81 | Q96GC5 | |
| YHGDSDLQLERINVY | 36 | Q13885 | |
| EKEQYSRLSGGGHYN | 156 | Q8TAV0 | |
| YNQHNSGSYLRDVLA | 11 | Q9NZI6 | |
| LHEETLTYLNQGQSY | 61 | Q9NZI6 | |
| GITYDHVELNVYLNG | 131 | Q5W111 | |
| EGGHLFLYYTVENSR | 561 | Q9H6W3 | |
| LERRYDLHSYQSGLI | 131 | Q96BD0 | |
| QYLYTGRLDIGVEHV | 171 | Q969K4 | |
| LQNLLGTHNLGRVYY | 521 | Q8N957 | |
| IGQIELYYDRGNHHE | 71 | Q4G0F5 | |
| AYHYRNRDGLSIQES | 811 | Q92738 | |
| GHLYNDLGLGYSQLQ | 236 | A2A3L6 | |
| AENIYEGGLNSDYVH | 116 | O14656 | |
| QNGHQEETSRYLDGY | 151 | Q68D42 | |
| YLAEGGRRQHSYTSN | 141 | Q13009 | |
| GRYEEYRGHSLDANS | 706 | Q8N7X1 | |
| YDIHQEIGRGAFSYL | 1601 | Q15772 | |
| YHGDSDLQLERINVY | 36 | P04350 | |
| LYSYLNDRQRHGLAS | 946 | Q6ZMY3 | |
| YHGDSDLQLERINVY | 36 | Q9BVA1 | |
| YHGDSDLQLERINVY | 36 | P68371 | |
| GYNNLEVAEYLLEHG | 846 | O95271 | |
| YHGDSDLQLDRISVY | 36 | P07437 | |
| LYTGLEYDLSRENHR | 851 | Q14997 | |
| DEGLYSRQLYVLGHE | 51 | P22314 | |
| GLRLIHYSYGVHDTN | 61 | A0A0K0K1A3 | |
| DAQVVLYRSYRHGDL | 2766 | P78527 | |
| HIRIQNSGDFYDLYG | 51 | P29350 | |
| ALGHDSSYYARIGDN | 231 | Q9BZF9 | |
| EYYNDSNGSHVLQGR | 106 | P25311 | |
| QSEYNNLHGLLTHYG | 1476 | Q96JM2 | |
| GYYRNLSLGLHVEVE | 871 | Q96Q05 | |
| QDLGHGLRLIYYSAA | 56 | A0A0K0K1G8 | |
| GLQFLIHYYNGEERA | 61 | A0A0B4J1U6 | |
| GYYDLQAVLTHQGRS | 416 | P54578 | |
| IHTGTLQRYQSYHIG | 16 | Q6ZNG1 | |
| TALLLYAGHQISRDY | 86 | Q96MT1 | |
| GDQYGNILHLYERDC | 251 | P11498 | |
| YGTELLRRYHENLSE | 461 | Q9NUA8 |